NatWest Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,691
| Closed | -$2.8M | – | 39 |
|
|
2024
Q1 | $2.8M | Sell |
6,691
-203
| -3% | -$84.9K | 1.08% | 28 |
|
|
2023
Q4 | $2.81M | Buy |
6,894
+1,068
| +18% | +$435K | 1.17% | 27 |
|
|
2023
Q3 | $2.03M | Buy |
5,826
+127
| +2% | +$44.2K | 1.06% | 28 |
|
|
2023
Q2 | $2.01M | Buy |
5,699
+14
| +0.2% | +$4.93K | 1.04% | 28 |
|
|
2023
Q1 | $1.79M | Sell |
5,685
-13,639
| -71% | -$4.3M | 0.97% | 30 |
|
|
2022
Q4 | $5.58M | Buy |
19,324
+406
| +2% | +$117K | 3.17% | 10 |
|
|
2022
Q3 | $5.48M | Buy |
+18,918
| New | +$5.48M | 3.18% | 9 |
|
|
2015
Q4 | – | Sell |
-7,054
| Closed | -$735K | – | 337 |
|
|
2015
Q3 | $735K | Buy |
+7,054
| New | +$735K | 0.02% | 223 |
|
|
2015
Q2 | – | Sell |
-7,664
| Closed | -$904K | – | 430 |
|
|
2015
Q1 | $904K | Buy |
7,664
+4,961
| +184% | +$585K | 0.01% | 231 |
|
|
2014
Q4 | $321 | Buy |
+2,703
| New | +$321 | ﹤0.01% | 369 |
|
|
2014
Q2 | – | Sell |
-15,145
| Closed | -$1.07M | – | 601 |
|
|
2014
Q1 | $1.07M | Sell |
15,145
-18,518
| -55% | -$1.31M | 0.05% | 237 |
|
|
2013
Q4 | $2.5M | Buy |
33,663
+5,629
| +20% | +$418K | 0.06% | 246 |
|
|
2013
Q3 | $2.13M | Buy |
28,034
+158
| +0.6% | +$12K | 0.06% | 252 |
|
|
2013
Q2 | $2.23M | Buy |
+27,876
| New | +$2.23M | 0.03% | 293 |
|